Perspective

Published on 06 Jan 2022

Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations

in Pharmacology of Anti-Cancer Drugs

Shelby Barnett
Victoria Holden
Quentin Campbell-Hewson
Gareth J. Veal

Frontiers in Oncology

doi 10.3389/fonc.2021.815040

2,671 views
4 citations

Original Research

Published on 06 Jan 2022

Effects of Intravenous Infusion of Lidocaine on Short-Term Outcomes and Survival in Patients Undergoing Surgery for Ovarian Cancer: A Retrospective Propensity Score Matching Study

in Pharmacology of Anti-Cancer Drugs

Hao Zhang
Jiahui Gu
Mengdi Qu
Zhirong Sun
Qihong Huang
Juan P. Cata
Wankun Chen
Changhong Miao

Frontiers in Oncology

doi 10.3389/fonc.2021.689832

3,614 views
13 citations

Review

Published on 05 Jan 2022

The Role of Circular RNAs in the Drug Resistance of Cancers

in Pharmacology of Anti-Cancer Drugs

Xin-Yuan Liu
Qi Zhang
Jing Guo
Peng Zhang
Hua Liu
Zi-Bin Tian
Cui-Ping Zhang
Xiao-Yu Li

Frontiers in Oncology

doi 10.3389/fonc.2021.790589

4,952 views
21 citations

Systematic Review

Published on 05 Jan 2022

A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy

in Pharmacology of Anti-Cancer Drugs

Alisha Joan Leen
Dominic Wei Ting Yap
Chong Boon Teo
Benjamin Kye Jyn Tan
Alex Molassiotis
Hiroshi Ishiguro
Sarah Wei Xian Fan
Raghav Sundar
Yu Yang Soon
Aishwarya Bandla

Frontiers in Oncology

doi 10.3389/fonc.2021.763229

6,993 views
12 citations

Case Report

Published on 05 Jan 2022

Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy

in Pharmacology of Anti-Cancer Drugs

Xiaoqian Zhai
Qiang Wu
Dan Pu
Liyuan Yin
Weiya Wang
Daxing Zhu
Feng Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.782682

2,870 views
5 citations

Original Research

Published on 03 Jan 2022

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

in Pharmacology of Anti-Cancer Drugs

Ruth M. Escalona
George Kannourakis
Jock K. Findlay
Nuzhat Ahmed

Frontiers in Oncology

doi 10.3389/fonc.2021.796588

3,614 views
20 citations

Original Research

Published on 03 Jan 2022

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

in Pharmacology of Anti-Cancer Drugs

Xinyu Zhou
Abel Soto-Gamez
Fleur Nijdam
Rita Setroikromo
Wim J. Quax

Frontiers in Oncology

doi 10.3389/fonc.2021.789336

3,844 views
10 citations

Original Research

Published on 24 Dec 2021

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

in Pharmacology of Anti-Cancer Drugs

Yan Zhang
Yanan Li
Zhe Zhuang
Wei Wang
Chong Wei
Danqing Zhao
Daobin Zhou
Wei Zhang

Frontiers in Oncology

doi 10.3389/fonc.2021.760405

8,283 views
36 citations

Original Research

Published on 23 Dec 2021

Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography

in Pharmacology of Anti-Cancer Drugs

Tian Xue
Chang Liu
Jing-Jing Liu
Yan-Hong Hao
Yan-Ping Shi
Xiu-Xiu Zhang
Yan-Jing Zhang
Yu-Fang Zhao
Li-Ping Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.794399

3,538 views
18 citations

Original Research

Published on 23 Dec 2021

Alterations in Intestinal Microbiota Composition in Mice Treated With Vitamin D3 or Cathelicidin

in Pharmacology of Anti-Cancer Drugs

Yu Jiang
Yue Wan
Jing Li
Yueshui Zhao
Yongshun Ma
Jing Yu
Donghong Yuan
Shixin Xiang
Fukuan Du
Xu Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.700038

2,387 views
5 citations

Case Report

Published on 23 Dec 2021

Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events

in Pharmacology of Anti-Cancer Drugs

Lingfang Tu
Yuan Ye
Xiaoping Tang
Zhen Liang
Qihan You
Jianying Zhou
Zhijie Pan

Frontiers in Oncology

doi 10.3389/fonc.2021.757069

2,760 views
11 citations

Original Research

Published on 23 Dec 2021

Nomograms Combining Ultrasonic Features With Clinical and Pathological Features for Estimation of Delphian Lymph Node Metastasis Risk in Papillary Thyroid Carcinoma

in Pharmacology of Anti-Cancer Drugs

Qi Qi
Pan Xu
Cheng Zhang
Suping Guo
Xingzhi Huang
Songli Chen
Yaohui Li
Aiyun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.792347

3,114 views
7 citations

Case Report

Published on 22 Dec 2021

Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer

in Pharmacology of Anti-Cancer Drugs

Georgios I. Papageorgiou
Evangelos Fergadis
Nikos Skouteris
Evridiki Christakos
Sergios A. Tsakatikas
Evangelos Lianos
Christos Kosmas

Frontiers in Oncology

doi 10.3389/fonc.2021.788809

6,334 views
11 citations

Original Research

Published on 20 Dec 2021

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

in Pharmacology of Anti-Cancer Drugs

Zhiming Jiao
Zhanchun Feng
Ziqi Yan
Jinwen Zhang
Gang Li
Ganyi Wang
Qianyu Wang
Da Feng

Frontiers in Oncology

doi 10.3389/fonc.2021.807171

2,596 views
3 citations

Review

Published on 17 Dec 2021

Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019

in Pharmacology of Anti-Cancer Drugs

Xuetong Chu
Yizhi Bu
Xiaoping Yang

Frontiers in Oncology

doi 10.3389/fonc.2021.785855

5,844 views
17 citations

Systematic Review

Published on 16 Dec 2021

Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis

in Pharmacology of Anti-Cancer Drugs

Songtao Li
Xiuyun He
Linjie Ruan
Ting Ye
Yulong Wen
Zhihua Song
Siying Hu
Yu Chen
Bo Peng
Shijie Li

Frontiers in Oncology

doi 10.3389/fonc.2021.804685

11,259 views
18 citations

Navigation group

Articles

Perspectives and Expertise in Establishing a Therapeutic Drug Monitoring Programme for Challenging Childhood Cancer Patient Populations

Effects of Intravenous Infusion of Lidocaine on Short-Term Outcomes and Survival in Patients Undergoing Surgery for Ovarian Cancer: A Retrospective Propensity Score Matching Study

The Role of Circular RNAs in the Drug Resistance of Cancers

A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy

Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy

Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment

Dihydroartemisinin-Transferrin Adducts Enhance TRAIL-Induced Apoptosis in Triple-Negative Breast Cancer in a P53-Independent and ROS-Dependent Manner

Preliminary Evaluation of Zanubrutinib-Containing Regimens in DLBCL and the Cerebrospinal Fluid Distribution of Zanubrutinib: A 13-Case Series

Analysis of the Relevance of the Ultrasonographic Features of Papillary Thyroid Carcinoma and Cervical Lymph Node Metastasis on Conventional and Contrast-Enhanced Ultrasonography

Alterations in Intestinal Microbiota Composition in Mice Treated With Vitamin D3 or Cathelicidin

Case Report: A Case of Sintilimab-Induced Cystitis/Ureteritis and Review of Sintilimab-Related Adverse Events

Nomograms Combining Ultrasonic Features With Clinical and Pathological Features for Estimation of Delphian Lymph Node Metastasis Risk in Papillary Thyroid Carcinoma

Case Report: Combination of Olaparib With Chemotherapy in a Patient With ATM-Deficient Colorectal Cancer

Suspected Adverse Drug Reactions in Pediatric Cancer Patients in China: An Analysis of Henan Province Spontaneous Reporting System Database

Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019

Protective Effect of Mannitol on Cisplatin-Induced Nephrotoxicity: A Systematic Review and Meta-Analysis